nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Cabazitaxel—prostate cancer	0.124	0.177	CbGbCtD
Olmesartan—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0792	0.113	CbGbCtD
Olmesartan—SLCO1B1—Cabazitaxel—prostate cancer	0.0722	0.103	CbGbCtD
Olmesartan—SLCO1B1—Estrone—prostate cancer	0.0705	0.101	CbGbCtD
Olmesartan—SLCO1B3—Estradiol—prostate cancer	0.0696	0.0994	CbGbCtD
Olmesartan—ABCC2—Ethinyl Estradiol—prostate cancer	0.0553	0.079	CbGbCtD
Olmesartan—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0462	0.066	CbGbCtD
Olmesartan—SLCO1B3—Docetaxel—prostate cancer	0.0416	0.0594	CbGbCtD
Olmesartan—ABCC2—Conjugated Estrogens—prostate cancer	0.0406	0.058	CbGbCtD
Olmesartan—SLCO1B1—Estradiol—prostate cancer	0.0405	0.0579	CbGbCtD
Olmesartan—ABCC2—Etoposide—prostate cancer	0.0232	0.0332	CbGbCtD
Olmesartan—ABCC2—Docetaxel—prostate cancer	0.0213	0.0304	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—prostate cancer	0.0159	0.0227	CbGbCtD
Olmesartan—Losartan—UGT2B17—prostate cancer	0.00278	0.624	CrCbGaD
Olmesartan—Telmisartan—CYP2C19—prostate cancer	0.000364	0.0816	CrCbGaD
Olmesartan—Tasosartan—CYP3A4—prostate cancer	0.000284	0.0636	CrCbGaD
Olmesartan—Losartan—CYP3A5—prostate cancer	0.000278	0.0623	CrCbGaD
Olmesartan—Losartan—ACE—prostate cancer	0.000256	0.0574	CrCbGaD
Olmesartan—Losartan—CYP2C19—prostate cancer	0.000189	0.0424	CrCbGaD
Olmesartan—Irbesartan—CYP3A4—prostate cancer	0.000186	0.0418	CrCbGaD
Olmesartan—Losartan—CYP3A4—prostate cancer	0.00012	0.0269	CrCbGaD
Olmesartan—Tachycardia—Docetaxel—prostate cancer	6.26e-05	0.000283	CcSEcCtD
Olmesartan—Headache—Estradiol—prostate cancer	6.24e-05	0.000282	CcSEcCtD
Olmesartan—Skin disorder—Docetaxel—prostate cancer	6.23e-05	0.000281	CcSEcCtD
Olmesartan—Agitation—Prednisone—prostate cancer	6.23e-05	0.000281	CcSEcCtD
Olmesartan—Oedema—Capecitabine—prostate cancer	6.21e-05	0.000281	CcSEcCtD
Olmesartan—Angioedema—Prednisone—prostate cancer	6.19e-05	0.00028	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—prostate cancer	6.17e-05	0.000279	CcSEcCtD
Olmesartan—Infection—Capecitabine—prostate cancer	6.17e-05	0.000279	CcSEcCtD
Olmesartan—Urticaria—Etoposide—prostate cancer	6.13e-05	0.000277	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—prostate cancer	6.12e-05	0.000276	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—prostate cancer	6.11e-05	0.000276	CcSEcCtD
Olmesartan—Malaise—Prednisone—prostate cancer	6.11e-05	0.000276	CcSEcCtD
Olmesartan—Shock—Capecitabine—prostate cancer	6.11e-05	0.000276	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—prostate cancer	6.1e-05	0.000276	CcSEcCtD
Olmesartan—Body temperature increased—Etoposide—prostate cancer	6.1e-05	0.000276	CcSEcCtD
Olmesartan—Abdominal pain—Etoposide—prostate cancer	6.1e-05	0.000276	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—prostate cancer	6.1e-05	0.000276	CcSEcCtD
Olmesartan—Nervous system disorder—Capecitabine—prostate cancer	6.09e-05	0.000275	CcSEcCtD
Olmesartan—Vertigo—Prednisone—prostate cancer	6.09e-05	0.000275	CcSEcCtD
Olmesartan—Thrombocytopenia—Capecitabine—prostate cancer	6.08e-05	0.000275	CcSEcCtD
Olmesartan—Syncope—Prednisone—prostate cancer	6.08e-05	0.000275	CcSEcCtD
Olmesartan—Tachycardia—Capecitabine—prostate cancer	6.06e-05	0.000274	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—prostate cancer	6.04e-05	0.000273	CcSEcCtD
Olmesartan—Skin disorder—Capecitabine—prostate cancer	6.03e-05	0.000272	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—prostate cancer	6.01e-05	0.000272	CcSEcCtD
Olmesartan—Hyperhidrosis—Capecitabine—prostate cancer	6e-05	0.000271	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—prostate cancer	6e-05	0.000271	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—prostate cancer	5.99e-05	0.000271	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—prostate cancer	5.98e-05	0.00027	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—prostate cancer	5.98e-05	0.00027	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—prostate cancer	5.97e-05	0.00027	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—prostate cancer	5.96e-05	0.000269	CcSEcCtD
Olmesartan—Anorexia—Capecitabine—prostate cancer	5.92e-05	0.000267	CcSEcCtD
Olmesartan—Nausea—Estradiol—prostate cancer	5.91e-05	0.000267	CcSEcCtD
Olmesartan—Vomiting—Mitoxantrone—prostate cancer	5.9e-05	0.000267	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—prostate cancer	5.89e-05	0.000266	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—prostate cancer	5.86e-05	0.000265	CcSEcCtD
Olmesartan—Rash—Mitoxantrone—prostate cancer	5.85e-05	0.000264	CcSEcCtD
Olmesartan—Dermatitis—Mitoxantrone—prostate cancer	5.84e-05	0.000264	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.84e-05	0.000264	CcSEcCtD
Olmesartan—Headache—Mitoxantrone—prostate cancer	5.81e-05	0.000263	CcSEcCtD
Olmesartan—Hypotension—Capecitabine—prostate cancer	5.8e-05	0.000262	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—prostate cancer	5.8e-05	0.000262	CcSEcCtD
Olmesartan—Myalgia—Prednisone—prostate cancer	5.77e-05	0.000261	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—prostate cancer	5.77e-05	0.000261	CcSEcCtD
Olmesartan—Anxiety—Prednisone—prostate cancer	5.75e-05	0.00026	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.73e-05	0.000259	CcSEcCtD
Olmesartan—Discomfort—Prednisone—prostate cancer	5.7e-05	0.000258	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.66e-05	0.000256	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—prostate cancer	5.65e-05	0.000255	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—prostate cancer	5.65e-05	0.000255	CcSEcCtD
Olmesartan—Insomnia—Capecitabine—prostate cancer	5.62e-05	0.000254	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—prostate cancer	5.59e-05	0.000253	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—prostate cancer	5.58e-05	0.000252	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—prostate cancer	5.56e-05	0.000251	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—prostate cancer	5.55e-05	0.000251	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—prostate cancer	5.54e-05	0.00025	CcSEcCtD
Olmesartan—Asthenia—Etoposide—prostate cancer	5.54e-05	0.00025	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—prostate cancer	5.54e-05	0.00025	CcSEcCtD
Olmesartan—Oedema—Prednisone—prostate cancer	5.53e-05	0.00025	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—prostate cancer	5.53e-05	0.00025	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—prostate cancer	5.53e-05	0.00025	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—prostate cancer	5.52e-05	0.00025	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—prostate cancer	5.52e-05	0.00025	CcSEcCtD
Olmesartan—Nausea—Mitoxantrone—prostate cancer	5.51e-05	0.000249	CcSEcCtD
Olmesartan—Infection—Prednisone—prostate cancer	5.5e-05	0.000248	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—prostate cancer	5.49e-05	0.000248	CcSEcCtD
Olmesartan—Pain—Docetaxel—prostate cancer	5.48e-05	0.000248	CcSEcCtD
Olmesartan—Constipation—Docetaxel—prostate cancer	5.48e-05	0.000248	CcSEcCtD
Olmesartan—Dyspepsia—Capecitabine—prostate cancer	5.47e-05	0.000247	CcSEcCtD
Olmesartan—Pruritus—Etoposide—prostate cancer	5.46e-05	0.000247	CcSEcCtD
Olmesartan—Shock—Prednisone—prostate cancer	5.44e-05	0.000246	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—prostate cancer	5.44e-05	0.000246	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—prostate cancer	5.42e-05	0.000245	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—prostate cancer	5.4e-05	0.000244	CcSEcCtD
Olmesartan—Decreased appetite—Capecitabine—prostate cancer	5.4e-05	0.000244	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—prostate cancer	5.38e-05	0.000243	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—prostate cancer	5.37e-05	0.000243	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Capecitabine—prostate cancer	5.36e-05	0.000242	CcSEcCtD
Olmesartan—Fatigue—Capecitabine—prostate cancer	5.35e-05	0.000242	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—prostate cancer	5.35e-05	0.000242	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—prostate cancer	5.33e-05	0.000241	CcSEcCtD
Olmesartan—Pain—Capecitabine—prostate cancer	5.31e-05	0.00024	CcSEcCtD
Olmesartan—Constipation—Capecitabine—prostate cancer	5.31e-05	0.00024	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—prostate cancer	5.3e-05	0.000239	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—prostate cancer	5.29e-05	0.000239	CcSEcCtD
Olmesartan—Diarrhoea—Etoposide—prostate cancer	5.28e-05	0.000239	CcSEcCtD
Olmesartan—Anorexia—Prednisone—prostate cancer	5.27e-05	0.000238	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—prostate cancer	5.24e-05	0.000237	CcSEcCtD
Olmesartan—Back pain—Epirubicin—prostate cancer	5.13e-05	0.000232	CcSEcCtD
Olmesartan—Feeling abnormal—Capecitabine—prostate cancer	5.12e-05	0.000231	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—prostate cancer	5.11e-05	0.000231	CcSEcCtD
Olmesartan—Dizziness—Etoposide—prostate cancer	5.1e-05	0.000231	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—prostate cancer	5.1e-05	0.00023	CcSEcCtD
Olmesartan—Gastrointestinal pain—Capecitabine—prostate cancer	5.08e-05	0.000229	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—prostate cancer	5.08e-05	0.000229	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—prostate cancer	5.07e-05	0.000229	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—prostate cancer	5.07e-05	0.000229	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—prostate cancer	5.04e-05	0.000228	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—prostate cancer	5.03e-05	0.000227	CcSEcCtD
Olmesartan—Insomnia—Prednisone—prostate cancer	5e-05	0.000226	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—prostate cancer	5e-05	0.000226	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—prostate cancer	4.98e-05	0.000225	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—prostate cancer	4.94e-05	0.000223	CcSEcCtD
Olmesartan—Urticaria—Capecitabine—prostate cancer	4.93e-05	0.000223	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—prostate cancer	4.92e-05	0.000222	CcSEcCtD
Olmesartan—Abdominal pain—Capecitabine—prostate cancer	4.91e-05	0.000222	CcSEcCtD
Olmesartan—Body temperature increased—Capecitabine—prostate cancer	4.91e-05	0.000222	CcSEcCtD
Olmesartan—Vomiting—Etoposide—prostate cancer	4.91e-05	0.000222	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—prostate cancer	4.9e-05	0.000222	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—prostate cancer	4.9e-05	0.000221	CcSEcCtD
Olmesartan—Agitation—Epirubicin—prostate cancer	4.87e-05	0.00022	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—prostate cancer	4.87e-05	0.00022	CcSEcCtD
Olmesartan—Rash—Etoposide—prostate cancer	4.87e-05	0.00022	CcSEcCtD
Olmesartan—Dermatitis—Etoposide—prostate cancer	4.86e-05	0.00022	CcSEcCtD
Olmesartan—Headache—Etoposide—prostate cancer	4.83e-05	0.000218	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—prostate cancer	4.81e-05	0.000217	CcSEcCtD
Olmesartan—Malaise—Epirubicin—prostate cancer	4.78e-05	0.000216	CcSEcCtD
Olmesartan—Fatigue—Prednisone—prostate cancer	4.77e-05	0.000215	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—prostate cancer	4.76e-05	0.000215	CcSEcCtD
Olmesartan—Syncope—Epirubicin—prostate cancer	4.75e-05	0.000215	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—prostate cancer	4.74e-05	0.000214	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—prostate cancer	4.74e-05	0.000214	CcSEcCtD
Olmesartan—Constipation—Prednisone—prostate cancer	4.73e-05	0.000214	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—prostate cancer	4.72e-05	0.000213	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—prostate cancer	4.68e-05	0.000212	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—prostate cancer	4.66e-05	0.00021	CcSEcCtD
Olmesartan—Cough—Epirubicin—prostate cancer	4.63e-05	0.000209	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—prostate cancer	4.62e-05	0.000209	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—prostate cancer	4.6e-05	0.000208	CcSEcCtD
Olmesartan—Nausea—Etoposide—prostate cancer	4.58e-05	0.000207	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisone—prostate cancer	4.56e-05	0.000206	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—prostate cancer	4.55e-05	0.000206	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—prostate cancer	4.54e-05	0.000205	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—prostate cancer	4.53e-05	0.000205	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—prostate cancer	4.52e-05	0.000204	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—prostate cancer	4.5e-05	0.000203	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.48e-05	0.000202	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—prostate cancer	4.46e-05	0.000201	CcSEcCtD
Olmesartan—Asthenia—Capecitabine—prostate cancer	4.46e-05	0.000201	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—prostate cancer	4.42e-05	0.0002	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—prostate cancer	4.41e-05	0.000199	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—prostate cancer	4.4e-05	0.000199	CcSEcCtD
Olmesartan—Urticaria—Prednisone—prostate cancer	4.39e-05	0.000199	CcSEcCtD
Olmesartan—Pruritus—Capecitabine—prostate cancer	4.39e-05	0.000198	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—prostate cancer	4.39e-05	0.000198	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—prostate cancer	4.39e-05	0.000198	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—prostate cancer	4.37e-05	0.000198	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—prostate cancer	4.37e-05	0.000198	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—prostate cancer	4.33e-05	0.000196	CcSEcCtD
Olmesartan—Oedema—Epirubicin—prostate cancer	4.33e-05	0.000195	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—prostate cancer	4.33e-05	0.000195	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—prostate cancer	4.31e-05	0.000195	CcSEcCtD
Olmesartan—Infection—Epirubicin—prostate cancer	4.3e-05	0.000194	CcSEcCtD
Olmesartan—Cough—Doxorubicin—prostate cancer	4.28e-05	0.000193	CcSEcCtD
Olmesartan—Shock—Epirubicin—prostate cancer	4.26e-05	0.000192	CcSEcCtD
Olmesartan—Diarrhoea—Capecitabine—prostate cancer	4.25e-05	0.000192	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—prostate cancer	4.24e-05	0.000192	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—prostate cancer	4.24e-05	0.000192	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—prostate cancer	4.24e-05	0.000191	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—prostate cancer	4.22e-05	0.000191	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—prostate cancer	4.2e-05	0.00019	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—prostate cancer	4.18e-05	0.000189	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—prostate cancer	4.18e-05	0.000189	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—prostate cancer	4.18e-05	0.000189	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—prostate cancer	4.18e-05	0.000189	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—prostate cancer	4.16e-05	0.000188	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.15e-05	0.000187	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—prostate cancer	4.13e-05	0.000186	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—prostate cancer	4.12e-05	0.000186	CcSEcCtD
Olmesartan—Dizziness—Capecitabine—prostate cancer	4.11e-05	0.000186	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—prostate cancer	4.08e-05	0.000184	CcSEcCtD
Olmesartan—Rash—Docetaxel—prostate cancer	4.04e-05	0.000183	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—prostate cancer	4.04e-05	0.000183	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—prostate cancer	4.04e-05	0.000183	CcSEcCtD
Olmesartan—Headache—Docetaxel—prostate cancer	4.02e-05	0.000182	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—prostate cancer	4e-05	0.000181	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—prostate cancer	4e-05	0.000181	CcSEcCtD
Olmesartan—Infection—Doxorubicin—prostate cancer	3.98e-05	0.00018	CcSEcCtD
Olmesartan—Asthenia—Prednisone—prostate cancer	3.97e-05	0.000179	CcSEcCtD
Olmesartan—Vomiting—Capecitabine—prostate cancer	3.95e-05	0.000178	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.94e-05	0.000178	CcSEcCtD
Olmesartan—Shock—Doxorubicin—prostate cancer	3.94e-05	0.000178	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—prostate cancer	3.93e-05	0.000177	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—prostate cancer	3.92e-05	0.000177	CcSEcCtD
Olmesartan—Rash—Capecitabine—prostate cancer	3.92e-05	0.000177	CcSEcCtD
Olmesartan—Pruritus—Prednisone—prostate cancer	3.91e-05	0.000177	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—prostate cancer	3.91e-05	0.000177	CcSEcCtD
Olmesartan—Dermatitis—Capecitabine—prostate cancer	3.91e-05	0.000177	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—prostate cancer	3.91e-05	0.000176	CcSEcCtD
Olmesartan—Headache—Capecitabine—prostate cancer	3.89e-05	0.000176	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—prostate cancer	3.89e-05	0.000176	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—prostate cancer	3.87e-05	0.000175	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—prostate cancer	3.82e-05	0.000172	CcSEcCtD
Olmesartan—Nausea—Docetaxel—prostate cancer	3.81e-05	0.000172	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—prostate cancer	3.81e-05	0.000172	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—prostate cancer	3.78e-05	0.000171	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—prostate cancer	3.76e-05	0.00017	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—prostate cancer	3.74e-05	0.000169	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—prostate cancer	3.73e-05	0.000169	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—prostate cancer	3.73e-05	0.000168	CcSEcCtD
Olmesartan—Pain—Epirubicin—prostate cancer	3.7e-05	0.000167	CcSEcCtD
Olmesartan—Constipation—Epirubicin—prostate cancer	3.7e-05	0.000167	CcSEcCtD
Olmesartan—Nausea—Capecitabine—prostate cancer	3.69e-05	0.000167	CcSEcCtD
Olmesartan—Dizziness—Prednisone—prostate cancer	3.66e-05	0.000165	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.65e-05	0.000165	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—prostate cancer	3.62e-05	0.000164	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—prostate cancer	3.57e-05	0.000161	CcSEcCtD
Olmesartan—Gastrointestinal pain—Epirubicin—prostate cancer	3.54e-05	0.00016	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—prostate cancer	3.52e-05	0.000159	CcSEcCtD
Olmesartan—Vomiting—Prednisone—prostate cancer	3.52e-05	0.000159	CcSEcCtD
Olmesartan—Rash—Prednisone—prostate cancer	3.49e-05	0.000158	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—prostate cancer	3.48e-05	0.000157	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—prostate cancer	3.48e-05	0.000157	CcSEcCtD
Olmesartan—Headache—Prednisone—prostate cancer	3.47e-05	0.000157	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.46e-05	0.000156	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—prostate cancer	3.45e-05	0.000156	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—prostate cancer	3.44e-05	0.000155	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—prostate cancer	3.42e-05	0.000155	CcSEcCtD
Olmesartan—Pain—Doxorubicin—prostate cancer	3.42e-05	0.000155	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—prostate cancer	3.42e-05	0.000154	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—prostate cancer	3.42e-05	0.000154	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—prostate cancer	3.3e-05	0.000149	CcSEcCtD
Olmesartan—Nausea—Prednisone—prostate cancer	3.29e-05	0.000148	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—prostate cancer	3.27e-05	0.000148	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—prostate cancer	3.18e-05	0.000144	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—prostate cancer	3.16e-05	0.000143	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—prostate cancer	3.16e-05	0.000143	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.13e-05	0.00042	CbGpPWpGaD
Olmesartan—Asthenia—Epirubicin—prostate cancer	3.1e-05	0.00014	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—SULT2A1—prostate cancer	3.1e-05	0.000416	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	3.09e-05	0.000415	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD17B3—prostate cancer	3.08e-05	0.000414	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACSL4—prostate cancer	3.08e-05	0.000414	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—VAV3—prostate cancer	3.08e-05	0.000413	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIST1H2BG—prostate cancer	3.08e-05	0.000413	CbGpPWpGaD
Olmesartan—Pruritus—Epirubicin—prostate cancer	3.06e-05	0.000138	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—MED12—prostate cancer	3.05e-05	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDE4D—prostate cancer	3.05e-05	0.000409	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRB7—prostate cancer	3.05e-05	0.000409	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	3.05e-05	0.000409	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNG5—prostate cancer	3.03e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ITPR1—prostate cancer	2.98e-05	0.000401	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.98e-05	0.0004	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIST1H4H—prostate cancer	2.97e-05	0.000399	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—prostate cancer	2.97e-05	0.000399	CbGpPWpGaD
Olmesartan—Diarrhoea—Epirubicin—prostate cancer	2.96e-05	0.000134	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	2.96e-05	0.000397	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PHGDH—prostate cancer	2.96e-05	0.000397	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ARG2—prostate cancer	2.96e-05	0.000397	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UMPS—prostate cancer	2.96e-05	0.000397	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.94e-05	0.000395	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.94e-05	0.000395	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA3—prostate cancer	2.91e-05	0.000391	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNG5—prostate cancer	2.9e-05	0.000389	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LDHB—prostate cancer	2.9e-05	0.000389	CbGpPWpGaD
Olmesartan—Asthenia—Doxorubicin—prostate cancer	2.87e-05	0.00013	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.86e-05	0.000385	CbGpPWpGaD
Olmesartan—Dizziness—Epirubicin—prostate cancer	2.86e-05	0.000129	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—CYP3A5—prostate cancer	2.85e-05	0.000382	CbGpPWpGaD
Olmesartan—Pruritus—Doxorubicin—prostate cancer	2.83e-05	0.000128	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.8e-05	0.000376	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HPGDS—prostate cancer	2.78e-05	0.000373	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C19—prostate cancer	2.76e-05	0.000371	CbGpPWpGaD
Olmesartan—Vomiting—Epirubicin—prostate cancer	2.75e-05	0.000124	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—PDHA1—prostate cancer	2.75e-05	0.000369	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA3—prostate cancer	2.75e-05	0.000369	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UCP3—prostate cancer	2.75e-05	0.000369	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TCN2—prostate cancer	2.75e-05	0.000369	CbGpPWpGaD
Olmesartan—Diarrhoea—Doxorubicin—prostate cancer	2.74e-05	0.000124	CcSEcCtD
Olmesartan—Rash—Epirubicin—prostate cancer	2.73e-05	0.000123	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—prostate cancer	2.73e-05	0.000123	CcSEcCtD
Olmesartan—Headache—Epirubicin—prostate cancer	2.71e-05	0.000122	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GSTT1—prostate cancer	2.7e-05	0.000362	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACHE—prostate cancer	2.7e-05	0.000362	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2A6—prostate cancer	2.67e-05	0.000358	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.66e-05	0.000357	CbGpPWpGaD
Olmesartan—Dizziness—Doxorubicin—prostate cancer	2.65e-05	0.00012	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—SLC22A3—prostate cancer	2.62e-05	0.000352	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD3B1—prostate cancer	2.62e-05	0.000352	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKR1C3—prostate cancer	2.59e-05	0.000348	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PRKACB—prostate cancer	2.58e-05	0.000346	CbGpPWpGaD
Olmesartan—Nausea—Epirubicin—prostate cancer	2.57e-05	0.000116	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CYP17A1—prostate cancer	2.55e-05	0.000343	CbGpPWpGaD
Olmesartan—Vomiting—Doxorubicin—prostate cancer	2.55e-05	0.000115	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.54e-05	0.000342	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTHLH—prostate cancer	2.53e-05	0.000339	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR1—prostate cancer	2.53e-05	0.000339	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.53e-05	0.000339	CbGpPWpGaD
Olmesartan—Rash—Doxorubicin—prostate cancer	2.52e-05	0.000114	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—prostate cancer	2.52e-05	0.000114	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.52e-05	0.000338	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TBXAS1—prostate cancer	2.51e-05	0.000338	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA4—prostate cancer	2.51e-05	0.000338	CbGpPWpGaD
Olmesartan—Headache—Doxorubicin—prostate cancer	2.51e-05	0.000113	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—AKR1C3—prostate cancer	2.49e-05	0.000334	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKACB—prostate cancer	2.47e-05	0.000332	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.46e-05	0.00033	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA2—prostate cancer	2.45e-05	0.000329	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA2—prostate cancer	2.43e-05	0.000327	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCG5—prostate cancer	2.42e-05	0.000325	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SULT1A1—prostate cancer	2.42e-05	0.000325	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—THBS1—prostate cancer	2.41e-05	0.000324	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP3CA—prostate cancer	2.41e-05	0.000324	CbGpPWpGaD
Olmesartan—Nausea—Doxorubicin—prostate cancer	2.38e-05	0.000107	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—ANXA1—prostate cancer	2.38e-05	0.000319	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTA1—prostate cancer	2.36e-05	0.000317	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTO1—prostate cancer	2.34e-05	0.000314	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NAT2—prostate cancer	2.34e-05	0.000314	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD3B2—prostate cancer	2.34e-05	0.000314	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCZ—prostate cancer	2.33e-05	0.000313	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC5A5—prostate cancer	2.32e-05	0.000312	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—prostate cancer	2.28e-05	0.000306	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.27e-05	0.000306	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2E1—prostate cancer	2.27e-05	0.000304	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PARP1—prostate cancer	2.25e-05	0.000302	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR4—prostate cancer	2.25e-05	0.000302	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.25e-05	0.000302	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NQO1—prostate cancer	2.24e-05	0.000301	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB2—prostate cancer	2.24e-05	0.000301	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LRP2—prostate cancer	2.24e-05	0.000301	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C18—prostate cancer	2.24e-05	0.000301	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALCA—prostate cancer	2.22e-05	0.000299	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TH—prostate cancer	2.21e-05	0.000297	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—P4HB—prostate cancer	2.2e-05	0.000295	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.19e-05	0.000295	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP3A4—prostate cancer	2.19e-05	0.000294	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.17e-05	0.000292	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—prostate cancer	2.17e-05	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1B1—prostate cancer	2.15e-05	0.000289	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC22A1—prostate cancer	2.14e-05	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.14e-05	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.11e-05	0.000284	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SULT2A1—prostate cancer	2.08e-05	0.00028	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GGT1—prostate cancer	2.08e-05	0.000279	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—prostate cancer	2.07e-05	0.000278	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOA1—prostate cancer	2.05e-05	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MED12—prostate cancer	2.05e-05	0.000275	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP9—prostate cancer	2.05e-05	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNG5—prostate cancer	2.03e-05	0.000273	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP19A1—prostate cancer	2.02e-05	0.000271	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—prostate cancer	2e-05	0.000269	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCQ—prostate cancer	1.98e-05	0.000266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGFR—prostate cancer	1.98e-05	0.000266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAP3K7—prostate cancer	1.96e-05	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA3—prostate cancer	1.96e-05	0.000263	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—RXRA—prostate cancer	1.95e-05	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.92e-05	0.000258	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.9e-05	0.000255	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF10—prostate cancer	1.88e-05	0.000253	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—COMT—prostate cancer	1.88e-05	0.000252	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—prostate cancer	1.87e-05	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HPGDS—prostate cancer	1.87e-05	0.000251	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—prostate cancer	1.86e-05	0.00025	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C19—prostate cancer	1.86e-05	0.000249	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ITPR1—prostate cancer	1.84e-05	0.000247	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—JAK2—prostate cancer	1.84e-05	0.000247	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAP2K1—prostate cancer	1.83e-05	0.000246	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—prostate cancer	1.82e-05	0.000244	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VAV3—prostate cancer	1.82e-05	0.000244	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACHE—prostate cancer	1.81e-05	0.000243	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—prostate cancer	1.81e-05	0.000243	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.81e-05	0.000243	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.81e-05	0.000243	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR2—prostate cancer	1.79e-05	0.000241	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2A6—prostate cancer	1.79e-05	0.000241	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.78e-05	0.00024	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITPR1—prostate cancer	1.76e-05	0.000237	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—prostate cancer	1.75e-05	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKR1C3—prostate cancer	1.74e-05	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TYMS—prostate cancer	1.74e-05	0.000233	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PRKACB—prostate cancer	1.73e-05	0.000233	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—prostate cancer	1.72e-05	0.000231	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP17A1—prostate cancer	1.72e-05	0.00023	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.7e-05	0.000228	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.69e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—prostate cancer	1.69e-05	0.000226	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1R—prostate cancer	1.69e-05	0.000226	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—prostate cancer	1.68e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—JAK2—prostate cancer	1.67e-05	0.000224	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA2—prostate cancer	1.63e-05	0.00022	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1A1—prostate cancer	1.63e-05	0.000219	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—prostate cancer	1.62e-05	0.000217	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ERCC2—prostate cancer	1.62e-05	0.000217	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—prostate cancer	1.6e-05	0.000215	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFRB—prostate cancer	1.6e-05	0.000215	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—prostate cancer	1.59e-05	0.000213	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITGB3—prostate cancer	1.56e-05	0.00021	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A5—prostate cancer	1.56e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—prostate cancer	1.52e-05	0.000205	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2E1—prostate cancer	1.52e-05	0.000205	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—prostate cancer	1.52e-05	0.000204	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB3—prostate cancer	1.51e-05	0.000203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR2—prostate cancer	1.51e-05	0.000203	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NQO1—prostate cancer	1.51e-05	0.000202	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—prostate cancer	1.49e-05	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TH—prostate cancer	1.48e-05	0.000199	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.47e-05	0.000198	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP3A4—prostate cancer	1.47e-05	0.000197	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.46e-05	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—prostate cancer	1.46e-05	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TERT—prostate cancer	1.45e-05	0.000195	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1B1—prostate cancer	1.44e-05	0.000194	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—prostate cancer	1.4e-05	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GGT1—prostate cancer	1.4e-05	0.000188	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—prostate cancer	1.39e-05	0.000186	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA1—prostate cancer	1.38e-05	0.000185	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP19A1—prostate cancer	1.36e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—prostate cancer	1.35e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—prostate cancer	1.34e-05	0.00018	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.34e-05	0.00018	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—prostate cancer	1.33e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—RXRA—prostate cancer	1.31e-05	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—prostate cancer	1.29e-05	0.000174	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—prostate cancer	1.28e-05	0.000171	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.27e-05	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BAD—prostate cancer	1.26e-05	0.00017	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—COMT—prostate cancer	1.26e-05	0.000169	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—prostate cancer	1.26e-05	0.000169	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ITPR1—prostate cancer	1.24e-05	0.000166	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—prostate cancer	1.22e-05	0.000164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—prostate cancer	1.22e-05	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.22e-05	0.000163	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGF—prostate cancer	1.21e-05	0.000162	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS1—prostate cancer	1.21e-05	0.000162	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—prostate cancer	1.21e-05	0.000162	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CREBBP—prostate cancer	1.18e-05	0.000159	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GSK3B—prostate cancer	1.17e-05	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TYMS—prostate cancer	1.17e-05	0.000157	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—prostate cancer	1.16e-05	0.000155	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—prostate cancer	1.15e-05	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CREBBP—prostate cancer	1.13e-05	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—prostate cancer	1.13e-05	0.000152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—prostate cancer	1.12e-05	0.000151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—prostate cancer	1.12e-05	0.00015	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—prostate cancer	1.11e-05	0.00015	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1A1—prostate cancer	1.09e-05	0.000147	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ERCC2—prostate cancer	1.09e-05	0.000146	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAP2K1—prostate cancer	1.08e-05	0.000145	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—prostate cancer	1.07e-05	0.000144	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—prostate cancer	1.06e-05	0.000143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—prostate cancer	1.06e-05	0.000143	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—prostate cancer	1.06e-05	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—prostate cancer	1.05e-05	0.000141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF2—prostate cancer	1.03e-05	0.000138	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—prostate cancer	1.02e-05	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—prostate cancer	1.01e-05	0.000136	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—prostate cancer	1e-05	0.000134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JAK2—prostate cancer	9.86e-06	0.000132	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—prostate cancer	9.77e-06	0.000131	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—prostate cancer	9.68e-06	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—prostate cancer	9.67e-06	0.00013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDM2—prostate cancer	9.63e-06	0.000129	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—prostate cancer	9.49e-06	0.000127	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—prostate cancer	9.41e-06	0.000126	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—prostate cancer	9.37e-06	0.000126	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—prostate cancer	9e-06	0.000121	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.99e-06	0.000121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—prostate cancer	8.79e-06	0.000118	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—prostate cancer	8.7e-06	0.000117	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—prostate cancer	8.62e-06	0.000116	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—prostate cancer	8.6e-06	0.000116	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—prostate cancer	8.57e-06	0.000115	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—prostate cancer	8.56e-06	0.000115	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—prostate cancer	8.45e-06	0.000113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—prostate cancer	8.39e-06	0.000113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CTNNB1—prostate cancer	8.3e-06	0.000112	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—prostate cancer	8.14e-06	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—prostate cancer	8.11e-06	0.000109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—prostate cancer	8.09e-06	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—EP300—prostate cancer	8.05e-06	0.000108	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CREBBP—prostate cancer	7.95e-06	0.000107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—prostate cancer	7.9e-06	0.000106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EP300—prostate cancer	7.72e-06	0.000104	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—prostate cancer	7.53e-06	0.000101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SRC—prostate cancer	7.51e-06	0.000101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—prostate cancer	7.31e-06	9.82e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—prostate cancer	7.24e-06	9.72e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—prostate cancer	7.11e-06	9.55e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—prostate cancer	6.73e-06	9.03e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—prostate cancer	6.71e-06	9.01e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—prostate cancer	6.58e-06	8.84e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—prostate cancer	6.57e-06	8.82e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—prostate cancer	6.51e-06	8.74e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—prostate cancer	6.21e-06	8.35e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—prostate cancer	5.96e-06	8e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—prostate cancer	5.71e-06	7.67e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—prostate cancer	5.67e-06	7.62e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—prostate cancer	5.52e-06	7.42e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—EP300—prostate cancer	5.41e-06	7.27e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—prostate cancer	5.06e-06	6.79e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—prostate cancer	4.87e-06	6.54e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—prostate cancer	4.66e-06	6.26e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—prostate cancer	4e-06	5.38e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—prostate cancer	3.27e-06	4.39e-05	CbGpPWpGaD
